[go: up one dir, main page]

WO2008137599A3 - Analogues de 2-alcoxyestradiol et préparations pharmaceutiques - Google Patents

Analogues de 2-alcoxyestradiol et préparations pharmaceutiques Download PDF

Info

Publication number
WO2008137599A3
WO2008137599A3 PCT/US2008/062294 US2008062294W WO2008137599A3 WO 2008137599 A3 WO2008137599 A3 WO 2008137599A3 US 2008062294 W US2008062294 W US 2008062294W WO 2008137599 A3 WO2008137599 A3 WO 2008137599A3
Authority
WO
WIPO (PCT)
Prior art keywords
alkoxyestradiol
analogs
pharmaceutical preparations
proliferative
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/062294
Other languages
English (en)
Other versions
WO2008137599A2 (fr
Inventor
Pemmaraju N Rao
James W Cessac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evestra Inc
Original Assignee
Evestra Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evestra Inc filed Critical Evestra Inc
Publication of WO2008137599A2 publication Critical patent/WO2008137599A2/fr
Publication of WO2008137599A3 publication Critical patent/WO2008137599A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne de nouveaux analogues de 2-alcoxyestradiol, des compositions pharmaceutiques et des procédés de traitement d'affections prolifératives et associées à l'angiogenèse.
PCT/US2008/062294 2007-05-01 2008-05-01 Analogues de 2-alcoxyestradiol et préparations pharmaceutiques Ceased WO2008137599A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91535907P 2007-05-01 2007-05-01
US60/915,359 2007-05-01
US94116207P 2007-05-31 2007-05-31
US60/941,162 2007-05-31

Publications (2)

Publication Number Publication Date
WO2008137599A2 WO2008137599A2 (fr) 2008-11-13
WO2008137599A3 true WO2008137599A3 (fr) 2008-12-24

Family

ID=39944205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/062294 Ceased WO2008137599A2 (fr) 2007-05-01 2008-05-01 Analogues de 2-alcoxyestradiol et préparations pharmaceutiques

Country Status (1)

Country Link
WO (1) WO2008137599A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110078604B (zh) * 2019-05-08 2021-12-03 台州学院 一种茚并茚酮衍生物的制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110183298B (zh) * 2019-05-10 2021-09-17 台州学院 一种二苯并戊烯衍生物的制备方法
CN111410677B (zh) * 2020-03-02 2023-05-30 周亚耀 2-甲氧基雌莫司汀及其衍生物、制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892069A (en) * 1993-08-06 1999-04-06 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6054598A (en) * 1997-03-13 2000-04-25 Pharm-Eco Laboratories, Inc. Synthesis of 2-alkoxyestradiols
US6852710B2 (en) * 2001-06-11 2005-02-08 Southwest Foundation For Biomedical Research 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892069A (en) * 1993-08-06 1999-04-06 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6054598A (en) * 1997-03-13 2000-04-25 Pharm-Eco Laboratories, Inc. Synthesis of 2-alkoxyestradiols
US6852710B2 (en) * 2001-06-11 2005-02-08 Southwest Foundation For Biomedical Research 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110078604B (zh) * 2019-05-08 2021-12-03 台州学院 一种茚并茚酮衍生物的制备方法

Also Published As

Publication number Publication date
WO2008137599A2 (fr) 2008-11-13

Similar Documents

Publication Publication Date Title
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2008136976A3 (fr) Composés pour traiter des troubles prolifératifs
WO2008057550A3 (fr) Stabilisation de vaccins par lyophilisation
WO2008049116A3 (fr) Indoles substitués
WO2011007230A3 (fr) Dérivés de triterpène de type lupéol comme antiviraux
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
WO2008024302A8 (fr) Composés pour le traitement de troubles prolifératifs
WO2010151541A8 (fr) Forme polymorphe d d'acetate de bazedoxifene et leurs procedes de preparation
WO2008005705A3 (fr) Formulations à teneur métallique et procédés d'utilisation
WO2012037411A3 (fr) Modulateurs des récepteurs des oestrogènes et leurs utilisations
WO2011156518A3 (fr) Modulateur du récepteur oestrogénique et utilisation de ces derniers
WO2011055215A3 (fr) Nouveaux modulateurs de kinase
MX348481B (es) Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas.
WO2010021717A3 (fr) Inhibiteurs de la protéase du vhc
MX2013000958A (es) Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
WO2009020631A3 (fr) Composés pour traiter des troubles prolifératifs
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
WO2011017502A3 (fr) Formulations comprenant du linaclotide
WO2008027600A3 (fr) Compositions d'imatinib
WO2011121576A3 (fr) Protéines et compositions immunogènes
WO2012103810A1 (fr) Certaines entités chimiques, compositions et procédés
WO2013080217A3 (fr) Formes cristallines de carbazitaxel et leur procédé de préparation
WO2009115084A3 (fr) Nouveaux dérivés de pyrrolopyrimidine et leurs utilisations
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2009094457A3 (fr) Benzhydryléthers substitués

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE